LEADER 00000cam 2200613Ii 4500 001 on1135758317 003 OCoLC 005 20200404105921.0 006 m o d 007 cr cnu---unuuu 008 200113s2020 ilu ob 001 0 eng d 020 9781610023535|q(electronic book) 020 1610023536|q(electronic book) 020 |z9781610023528 035 (OCoLC)1135758317 037 MA0935|bAmerican Academy of Pediatrics 040 N$T|beng|erda|epn|cN$T|dN$T|dEBLCP|dKXN|dOCLCF|dNEH|dTETON |dUPM 049 STJP 050 4 RJ53.A5 060 4 QV 39 072 7 MED|x069000|2bisacsh 072 7 MED|x071000|2bisacsh 072 7 MED|x022090|2bisacsh 072 7 MED|x115000|2bisacsh 082 04 615.3/29083|223 099 WORLD|aWIDE|aWEB|aE-BOOK|aPROQUESTEBC 245 00 2020 Nelson's pediatric antimicrobial therapy /|cJohn S. Bradley, MD, editor in chief, John D. Nelson, MD, emeritus ; Elizabeth D. Barnett, MD [and six others], contributing editors. 246 3 Nelson's pediatric antimicrobial therapy 246 3 Pediatric antimicrobial therapy 250 26th edition. 264 1 Itasca, IL :|bAmerican Academy of Pediatrics,|c2020. 300 1 online resource 336 text|btxt|2rdacontent 337 computer|bc|2rdamedia 338 online resource|bcr|2rdacarrier 504 Includes bibliographical references and index. 505 0 Machine generated contents note: 1.Choosing Among Antibiotics Within a Class: Beta-lactams and Beta- lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones -- 2.Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins -- 3.How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes -- 4.Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and MethiciIlin-Resistant Staphylococcus aureus -- 5.Antimicrobial Therapy for Newborns -- A.Recommended Therapy for Selected Newborn Conditions -- B.Antimicrobial Dosages for Neonates -- C.Aminoglycosides -- D.Vancomycin -- E.Use of Antimicrobials During Pregnancy or Breastfeeding -- 6.Antimicrobial Therapy According to Clinical Syndromes -- A.Skin and Soft Tissue Infections -- B.Skeletal Infections -- C.Eye Infections -- D.Ear and Sinus Infections -- E.Oropharyngeal Infections -- F.Lower Respiratory Tract Infections -- G.Cardiovascular Infections -- H.Gastrointestinal Infections -- I.Genital and Sexually Transmitted Infections -- J.Central Nervous System Infections -- K.Urinary Tract Infections -- L.Miscellaneous Systemic Infections -- 7.Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens -- A.Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive) -- B.Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative) -- C.Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes) -- D.Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens -- 8.Preferred Therapy for Specific Fungal Pathogens -- A.Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities -- B.Systemic Infections -- C.Localized Mucocutaneous Infections -- 9.Preferred Therapy for Specific Viral Pathogens -- A.Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals -- B.Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals -- C.Preferred Therapy for Specific Viral Pathogens -- 10.Preferred Therapy for Specific Parasitic Pathogens -- A.Selected Common Pathogenic Parasites and Suggested Agents for Treatment -- B.Preferred Therapy for Specific Parasitic Pathogens -- 11.Alphabetic Listing of Antimicrobials -- A.Systemic Antimicrobials With Dosage Forms and Usual Dosages -- B.Topical Antimicrobials (Skin, Eye, Ear, Mucosa) -- 12.Antibiotic Therapy for Children Who Are Obese -- 13.Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections -- 14.Antimicrobial Prophylaxis/Prevention of Symptomatic Infection -- A.Postexposure Antimicrobial Prophylaxis to Prevent Infection -- B.Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection -- C.Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection -- D.Surgical/Procedure Prophylaxis. 520 This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. 588 0 Online resource; title from PDF title page (EBSCO, viewed January 15, 2020) 650 0 Antibiotics|vHandbooks, manuals, etc. 650 0 Anti-infective agents|vHandbooks, manuals, etc. 650 0 Communicable diseases in children|xChemotherapy|vHandbooks, manuals, etc. 650 2 Anti-Bacterial Agents|xtherapeutic use. 650 7 MEDICAL|xPediatrics MEDICAL|xInfectious Diseases MEDICAL |xInfection Control MEDICAL|xPharmacology.|2bisacsh 650 7 Anti-infective agents.|2fast|0(OCoLC)fst00810345 650 7 Communicable diseases in children|xChemotherapy.|2fast |0(OCoLC)fst00869936 655 0 Electronic books. 655 7 Handbooks and manuals.|2fast|0(OCoLC)fst01423877 700 1 Bradley, John S.|q(John Scott),|eeditor. 700 1 Nelson, John D.,|d1930-|eeditor. 710 2 American Academy of Pediatrics,|epublisher. 994 C0|bSTJ
|